Pain Response to Radium-223 in Men With Metastatic Castrate-Resistant Prostate Cancer

被引：1
|
作者：
Zhang, I. [1 ,2 ]
Gilbo, P. [1 ,2 ]
Cox, B. W. [1 ,2 ]
机构：
[1] Northwell Hlth, Dept Radiat Med, Lake Success, NY USA
[2] Hofstra Northwell Sch Med, Hempstead, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1873
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3259
引用
收藏
页码：E530 / E530
页数：1
相关论文
共 50 条
  • [31] Use of radium-223 in heavily pretreated metastatic castrate resistant prostate cancer (mCRPC) patients.
    Modi, Dipenkumar
    Kim, SeongHo
    Mamdani, Hirva Mansurali
    Hwang, Clara
    Gayar, Hersham
    Vaishampayan, Ulka N.
    Joyrich, Richard
    Heath, Elisabeth I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [32] Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer
    Armstrong, Andrew J.
    Gupta, Santosh
    Healy, Patrick
    Kemeny, Gabor
    Leith, Beth
    Zalutsky, Michael R.
    Spritzer, Charles
    Davies, Catrin
    Rothwell, Colin
    Ware, Kathryn
    Somarelli, Jason A.
    Wood, Kris
    Ribar, Thomas
    Giannakakou, Paraskevi
    Zhang, Jiaren
    Gerber, Drew
    Anand, Monika
    Foo, Wen-Chi
    Halabi, Susan
    Gregory, Simon G.
    George, Daniel J.
    [J]. PLOS ONE, 2019, 14 (05):
  • [33] Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223
    Roviello, Giandomenico
    Gallicchio, Rosj
    Bozza, Giovanni
    Rodriquenz, Maria Grazia
    Aieta, Michele
    Storto, Giovanni
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 9 - 13
  • [34] Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging
    Iizuka, Junpei
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 16 - 23
  • [35] Pain response in a Population-based study of Radium-223 for Metastatic Prostate Cancer
    Tyldesley, S.
    Parimi, S.
    Tsang, E.
    Bachand, F.
    Aparicio, M.
    Duncan, G.
    Sunderland, K.
    Olson, R.
    Pai, H.
    Alexander, A.
    Lapointe, V.
    Chi, K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S729 - S729
  • [36] Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223
    Hijab, Adham
    Curcean, Sebastian
    Tunariu, Nina
    Tovey, Holly
    Alonzi, Roberto
    Staffurth, John
    Blackledge, Matthew
    Padhani, Anwar
    Tree, Alison
    Stidwill, Helen
    Finch, Jessica
    Chatfield, Peter
    Perry, Sophie
    Koh, Dow Mu
    Hall, Emma
    Parker, Chris
    [J]. CLINICAL GENITOURINARY CANCER, 2021, 19 (05) : E299 - E305
  • [37] Retreatment of Men With Metastatic Castrate-Resistant Prostate Cancer With Abiraterone
    Leibowitz-Amit, Raya
    Alimohamed, Nimira
    Vera-Badillo, Francisco E.
    Seah, Jo-An
    Templeton, Arnoud J.
    Knox, Jennifer J.
    Tannock, Ian F.
    Sridhar, Srikala S.
    Joshua, Anthony M.
    [J]. PROSTATE, 2014, 74 (14): : 1462 - 1464
  • [38] Radium-223 in the treatment of metastatic prostate cancer
    Marques, I. A.
    Abrantes, A. M.
    Pires, A. S.
    Costa, G.
    Tavares-Silva, E.
    Botelho, M. F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S47 - S47
  • [39] Randomized phase II study of sipuleucel-T (SipT) with or without radium-223 (Ra223) in men with asymptomatic bone-metastatic castrate-resistant prostate cancer (mCRPC)
    Marshall, Catherine Handy
    Park, Jong Chul
    DeWeese, Theodore L.
    King, Serina
    Afful, Michaella
    Hurrelbrink, Julia
    Manogue, Charlotte
    Cotogno, Patrick
    Moldawer, Nancy P.
    Barata, Pedro C.
    Drake, Charles G.
    Posadas, Edwin M.
    Armstrong, Andrew J.
    Sartor, A. Oliver
    Antonarakis, Emmanuel S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [40] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    [J]. INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
12345